Apnimed, Inc.

APMD Nasdaq Healthcare · Pharmaceutical Preparations Cambridge, MA apnimed.com
$17.56
Mkt Cap 731.0M

Developer of oral drug therapies for obstructive sleep apnea, a condition in which breathing repeatedly stops during sleep.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…